Search results (128)
« Back to Publications8-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in children in Nepal (TyVOID): a prospective cohort follow-up study of the TyVAC Nepal randomised controlled trial.
Journal article
Pant D. et al, (2027), Lancet Glob Health
Impact of dosing interval on immunogenicity following a heterologous typhoid conjugate vaccine booster in Nepalese children: an observational study.
Journal article
Zhang Y. et al, (2026), J Infect
COVID-19 vaccine effectiveness and SARS-CoV-2 variants in Nepal: Test-negative case-control study and genetic sequencing (COVVAR Nepal)
Journal article
Pokhrel B. et al, (2026), Vaccine X, 31
Typhoid Seroepidemiology for TCV Decision‑Making Meeting Report of the 18 July 2025 Expert Consultation
Preprint
Laurens M. et al, (2026)
Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.
Journal article
Khanam F. et al, (2026), Clin Infect Dis
A national programme of bivalent prefusion F vaccination in pregnancy and protection against respiratory syncytial virus hospitalisation in infants until age 6 months in the UK: a multicentre, prospective, test-negative, case-control study.
Journal article
O'Hagan S. et al, (2026), Lancet Child Adolesc Health
Studying Early Life Live-Attenuated influenza virus immune Responses (STELLAR): study protocol for an exploratory observational study of the nasal mucosal and systemic immune response in healthy children given an intranasal live-attenuated influenza vaccine.
Journal article
Kelleher K. et al, (2026), BMJ Open, 16
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.
Journal article
Hagedoorn NN. et al, (2026), Vaccine, 85
Maternal views on RSV vaccination in the UK's second season.
Journal article
O'Hagan S. et al, (2026), Lancet Infect Dis, 26, e209 - e211
The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.
Journal article
Zhang Y. et al, (2026), EClinicalMedicine, 94
Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.
Journal article
Bijukchhe SM. et al, (2026), Lancet Infect Dis
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.
Journal article
Liatsikos K. et al, (2026), Lancet Microbe, 7
Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and Scotland.
Journal article
O'Hagan S. et al, (2026), Arch Dis Child
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections
Preprint
Hagedoorn N. et al, (2026)